FindTrial
Sign In

Retrospective Assessment of Treatments of Hospitalized COVID19 Patients.

Retrospective Assessment of Treatments of Hospitalized Covid-19 Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025371
Enrollment
500
Registered
2020-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B338- Other specified viral diseases

Interventions

None listed

Sponsors

Entrepreneurship Development Center Venture Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Data of the following types of subjects will be considered for inclusion: 1. Patients diagnosed to be infected by Covid -19 by RT PCR. 2. Patients who have either been discharged or have died of Covid-19 infection.

Exclusion criteria

Exclusion criteria: NIL

Design outcomes

Primary

MeasureTime frame
Time to recovery/ discharge or death in hospitalized COVID-19 patients.Timepoint: At recovery/ discharge or death.—

Secondary

MeasureTime frame
Adverse events (AEs) and Serious Adverse Events (SAEs) recorded during treatment in the hospital.Timepoint: During hospitalisation.;Death rate in hospitalized COVID-19 patients.Timepoint: During hospitalisation.;Need for additional supportive measures in COVID-19 patients.Timepoint: During hospitalisation.—

Countries

India

Contacts

Public ContactDr Ravindra Ghooi

Pulmocare Research and Education (PURE) Foundation

sundeepsalvi@gmail.com9921211000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026